Jarret Engstrom

Long-acting rilpivirine as potential pre-exposure prophylaxis for HIV-1 prevention (the MWRI-01 study): an open-label, phase 1, compartmental, pharmacokinetic and pharmacodynamic assessment

Ian McGowan, Charlene S. Dezzutti, Aaron Siegel et al. · The Lancet HIV · 2016 · 76 citations

Drug Safety, Treatment And Prevention, Pharmacology +7

A Phase 1 Randomized, Open Label, Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Three Formulations of Tenofovir 1% Gel (the CHARM-01 Study)

Ian McGowan, Ross Cranston, Kathryn Duffill et al. · PLoS ONE · 2015 · 57 citations · Full text

Project Gel a Randomized Rectal Microbicide Safety and Acceptability Study in Young Men and Transgender Women

Ian McGowan, Ross Cranston, Kenneth H. Mayer et al. · PLoS ONE · 2016 · 15 citations · Full text

Tofacitinib inhibits inflammatory cytokines from ulcerative colitis and healthy mucosal explants and is associated with pSTAT1/3 reduction in T-cells

Rhonda M. Brand, Beverley A. Moore, Ashley Zyhowski et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 2020 · 15 citations · Full text

A Multiple Dose Phase 1 Assessment of Rilpivirine Long Acting in a Model of Preexposure Prophylaxis Against HIV

Ross Cranston, Charlene S. Dezzutti, Aaron Siegel et al. · AIDS Research and Human Retroviruses · 2019 · 11 citations